J Renal Inj Prev. 2017;6(1): 18-25. doi: 10.15171/jrip.2017.04
PMID: 28487867        PMCID: PMC5414514

Case Report

Non-ischemic cardiomyopathy after rituximab treatment for membranous nephropathy


Cited by CrossRef: 3


1- Takahashi T, Okamoto T, Sato Y, Yamazaki T, Hayashi A, Aoyagi H, Ueno M, Kobayashi N, Uetake K, Nakanishi M, Ariga T. Periodically repeated rituximab administrations in children with refractory nephrotic syndrome: 2-year multicenter observational study. Pediatr Nephrol. 2019;34(1):87 [Crossref]
2- Farkas A, Marcott M, Yanta J, Pizon A. Bicarbonate refractory QRS prolongation and left bundle‐branch block following escitalopram and lamotrigine overdose: A case report and literature review of toxic left bundle‐branch block. J Clin Pharm Ther. 2018;43(5):717 [Crossref]
3- Pozdzik A, Brochériou I, David C, Touzani F, Goujon J, Wissing K. Membranous Nephropathy and Anti-Podocytes Antibodies: Implications for the Diagnostic Workup and Disease Management. BioMed Research International. 2018;2018:1 [Crossref]